patients with objectively measurable soft tissue sarcoma , bone sarcoma , or mesothelioma who had failed at least one prior chemotherapy regimen received either bleomycin ( 20 u/m2 i.v . day 1 each week ) , chlorozotocin ( 150 mg/m2 i.v . q6 weeks ) , mgbg ( 500 mg/m2 i.v . each week , escalated in 50 mg/m2 weekly increments to a maximum dose of 700 mg/m2 ) , or bruceantin ( 5.5 mg/m2 days 1 , 8 , 15 , and 22 , with cycles repeated every 6 weeks ) .
C1261473
soft tissue sarcoma
C0029463
bone sarcoma